article_metadata: Asim Kichloo Michael S Albosta Shane McMahon Kimberly Movsesian Farah Wani Shakeel M Jamal Michael Aljadah Jagmeet Singh
article_metadata: 10.1177/2324709620951339
article_metadata: J Investig Med High Impact Case Rep
article_metadata: 2020 Jan-Dec;8:2324709620951339.
article_metadata: diabetic ketoacidosis immunotherapy pembrolizumab
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/32830561/
article_metadata: Adenocarcinoma / secondary Antineoplastic Agents, Immunological / adverse effects Colonic Neoplasms / drug therapy Diabetic Ketoacidosis / chemically induced
article_metadata: Adenocarcinoma / secondary Antineoplastic Agents, Immunological / adverse effects Colonic Neoplasms / drug therapy Diabetic Ketoacidosis / chemically induced Case Reports Adenocarcinoma / drug therapy Aged Antibodies, Monoclonal, Humanized Female Humans Immunotherapy / adverse effects Programmed Cell Death 1 Receptor / antagonists & inhibitors Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological Programmed Cell Death 1 Receptor pembrolizumab
article_metadata: PMC7448133
article_metadata: 32830561
article_metadata: Pembrolizumab-Induced Diabetes Mellitus Presenting as Diabetic Ketoacidosis in a Patient With Metastatic Colonic Adenocarcinoma
article_metadata: 2020